Details for Patent: 7,687,662
✉ Email this page to a colleague
Which drugs does patent 7,687,662 protect, and when does it expire?
Patent 7,687,662 protects NINLARO and is included in one NDA.
This patent has sixty patent family members in thirty-six countries.
Summary for Patent: 7,687,662
Title: | Proteasome inhibitors |
Abstract: | The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. |
Inventor(s): | Olhava; Edward J. (Newton, MA), Danca; Mihaela Diana (Mendham, NJ) |
Assignee: | Millennium Pharmaceuticals, Inc. (Cambridge, MA) |
Application Number: | 12/217,243 |
Patent Claim Types: see list of patent claims | Compound; Composition; |
Drugs Protected by US Patent 7,687,662
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | NINLARO | ixazomib citrate | CAPSULE;ORAL | 208462-001 | Nov 20, 2015 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
Takeda Pharms Usa | NINLARO | ixazomib citrate | CAPSULE;ORAL | 208462-002 | Nov 20, 2015 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
Takeda Pharms Usa | NINLARO | ixazomib citrate | CAPSULE;ORAL | 208462-003 | Nov 20, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,687,662
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2178888 | ⤷ Sign Up | PA2017010 | Lithuania | ⤷ Sign Up |
European Patent Office | 2178888 | ⤷ Sign Up | 300871 | Netherlands | ⤷ Sign Up |
European Patent Office | 2178888 | ⤷ Sign Up | 122017000025 | Germany | ⤷ Sign Up |
European Patent Office | 2178888 | ⤷ Sign Up | CA 2017 00014 | Denmark | ⤷ Sign Up |
European Patent Office | 2178888 | ⤷ Sign Up | C20170014 00227 | Estonia | ⤷ Sign Up |
European Patent Office | 2178888 | ⤷ Sign Up | PA2017010,C2178888 | Lithuania | ⤷ Sign Up |
European Patent Office | 2178888 | ⤷ Sign Up | LUC00013 | Luxembourg | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |